Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (1->4)-beta-D-glucan | multiple interactions | ISO | Miox (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of MIOX mRNA | CTD | PMID:36331819 | 1,1-dichloroethene | decreases expression | ISO | Miox (Mus musculus) | 6480464 | vinylidene chloride results in decreased expression of MIOX mRNA | CTD | PMID:26682919 | 1,2-dimethylhydrazine | increases expression | ISO | Miox (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in increased expression of MIOX mRNA | CTD | PMID:22206623 | 17beta-estradiol | increases expression | ISO | MIOX (Homo sapiens) | 6480464 | Estradiol results in increased expression of MIOX mRNA | CTD | PMID:31614463 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | AHR protein alternative form affects the reaction [Tetrachlorodibenzodioxin results in decreased expression of MIOX mRNA] | CTD | PMID:21215274 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of MIOX mRNA | CTD | PMID:21215274 | 2,4-dinitrotoluene | affects expression | EXP | | 6480464 | 2 and 4-dinitrotoluene affects the expression of MIOX mRNA | CTD | PMID:21346803 | 3-chloropropane-1,2-diol | decreases expression | EXP | | 6480464 | alpha-Chlorohydrin results in decreased expression of MIOX protein | CTD | PMID:34915118 | 4,4'-sulfonyldiphenol | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of MIOX mRNA | CTD | PMID:36041667 | acetamide | decreases expression | EXP | | 6480464 | acetamide results in decreased expression of MIOX mRNA | CTD | PMID:31881176 | all-trans-retinoic acid | multiple interactions | ISO | Miox (Mus musculus) | 6480464 | [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of MIOX mRNA | CTD | PMID:36189433 | all-trans-retinoic acid | decreases expression | ISO | Miox (Mus musculus) | 6480464 | Tretinoin results in decreased expression of MIOX mRNA | CTD | PMID:36189433 | ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of MIOX mRNA | CTD | PMID:16483693 | benzo[a]pyrene | increases mutagenesis | ISO | MIOX (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased mutagenesis of MIOX gene | CTD | PMID:25435355 | benzo[a]pyrene | affects methylation | ISO | MIOX (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of MIOX 5' UTR and Benzo(a)pyrene affects the methylation of MIOX promoter | CTD | PMID:27901495 | benzo[a]pyrene | increases expression | ISO | Miox (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of MIOX mRNA | CTD | PMID:32417428 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of MIOX mRNA | CTD | PMID:25181051 | bisphenol A | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of MIOX mRNA | CTD | PMID:36041667 | bisphenol A | increases methylation | EXP | | 6480464 | bisphenol A results in increased methylation of MIOX gene | CTD | PMID:28505145 | bisphenol F | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of MIOX mRNA | CTD | PMID:36041667 | carbon nanotube | increases expression | ISO | Miox (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25620056 | choline | multiple interactions | ISO | Miox (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MIOX mRNA | CTD | PMID:20938992 | ciguatoxin CTX1B | affects expression | ISO | Miox (Mus musculus) | 6480464 | Ciguatoxins affects the expression of MIOX mRNA | CTD | PMID:18353800 | cisplatin | increases expression | ISO | Miox (Mus musculus) | 6480464 | Cisplatin results in increased expression of MIOX protein | CTD | PMID:37863467 | cisplatin | increases expression | ISO | MIOX (Homo sapiens) | 6480464 | Cisplatin results in increased expression of MIOX protein | CTD | PMID:37863467 | dextran sulfate | multiple interactions | ISO | Miox (Mus musculus) | 6480464 | [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of MIOX mRNA | CTD | PMID:29950665 | dibutyl phthalate | decreases expression | ISO | Miox (Mus musculus) | 6480464 | Dibutyl Phthalate results in decreased expression of MIOX mRNA | CTD | PMID:17361019 and PMID:21266533 | diethylstilbestrol | affects expression | EXP | | 6480464 | Diethylstilbestrol affects the expression of MIOX mRNA | CTD | PMID:36653537 | finasteride | increases expression | EXP | | 6480464 | Finasteride results in increased expression of MIOX mRNA | CTD | PMID:24136188 | flutamide | increases expression | EXP | | 6480464 | Flutamide results in increased expression of MIOX mRNA | CTD | PMID:24136188 | flutamide | decreases expression | EXP | | 6480464 | Flutamide results in decreased expression of MIOX mRNA | CTD | PMID:24793618 | folic acid | multiple interactions | ISO | Miox (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MIOX mRNA | CTD | PMID:20938992 | glafenine | increases expression | EXP | | 6480464 | Glafenine results in increased expression of MIOX mRNA | CTD | PMID:24136188 | GW 4064 | increases expression | ISO | Miox (Mus musculus) | 6480464 | GW 4064 results in increased expression of MIOX mRNA | CTD | PMID:26655953 | inositol | affects binding | ISO | Miox (Mus musculus) | 6480464 | [MIOX protein binds to Iron] which binds to Inositol | CTD | PMID:17012379 | iron atom | affects binding | ISO | Miox (Mus musculus) | 6480464 | [MIOX protein binds to Iron] which binds to Inositol | CTD | PMID:17012379 | iron(0) | affects binding | ISO | Miox (Mus musculus) | 6480464 | [MIOX protein binds to Iron] which binds to Inositol | CTD | PMID:17012379 | L-methionine | multiple interactions | ISO | Miox (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MIOX mRNA | CTD | PMID:20938992 | lead diacetate | increases expression | ISO | Miox (Mus musculus) | 6480464 | lead acetate results in increased expression of MIOX mRNA | CTD | PMID:22609695 | lead diacetate | decreases expression | EXP | | 6480464 | lead acetate results in decreased expression of MIOX mRNA | CTD | PMID:22641619 | mono(2-ethylhexyl) phthalate | decreases expression | ISO | Miox (Mus musculus) | 6480464 | mono-(2-ethylhexyl)phthalate results in decreased expression of MIOX mRNA | CTD | PMID:36189433 | mono(2-ethylhexyl) phthalate | multiple interactions | ISO | Miox (Mus musculus) | 6480464 | [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of MIOX mRNA | CTD | PMID:36189433 | Muraglitazar | increases expression | EXP | | 6480464 | muraglitazar results in increased expression of MIOX mRNA | CTD | PMID:21515302 | N-methyl-4-phenylpyridinium | increases expression | ISO | MIOX (Homo sapiens) | 6480464 | 1-Methyl-4-phenylpyridinium results in increased expression of MIOX mRNA | CTD | PMID:24810058 | N-methyl-4-phenylpyridinium | increases expression | EXP | | 6480464 | 1-Methyl-4-phenylpyridinium results in increased expression of MIOX mRNA | CTD | PMID:28801915 | N-nitrosodiethylamine | increases expression | ISO | Miox (Mus musculus) | 6480464 | Diethylnitrosamine results in increased expression of MIOX mRNA | CTD | PMID:24535843 | nefazodone | increases expression | EXP | | 6480464 | nefazodone results in increased expression of MIOX mRNA | CTD | PMID:24136188 | ochratoxin A | affects expression | EXP | | 6480464 | ochratoxin A affects the expression of MIOX mRNA | CTD | PMID:32468156 | paracetamol | affects expression | ISO | Miox (Mus musculus) | 6480464 | Acetaminophen affects the expression of MIOX mRNA | CTD | PMID:17562736 | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Miox (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of MIOX mRNA | CTD | PMID:36331819 | perfluorooctanoic acid | increases expression | EXP | | 6480464 | perfluorooctanoic acid results in increased expression of MIOX mRNA | CTD | PMID:28511854 | pirinixic acid | increases expression | EXP | | 6480464 | pirinixic acid results in increased expression of MIOX mRNA | CTD | PMID:22484513 | pirinixic acid | increases expression | ISO | Miox (Mus musculus) | 6480464 | pirinixic acid results in increased expression of MIOX mRNA | CTD | PMID:23811191 | pravastatin | decreases expression | ISO | Miox (Mus musculus) | 6480464 | Pravastatin results in decreased expression of MIOX mRNA | CTD | PMID:27225895 | pregnenolone 16alpha-carbonitrile | increases expression | ISO | Miox (Mus musculus) | 6480464 | Pregnenolone Carbonitrile results in increased expression of MIOX mRNA | CTD | PMID:22698814 | propanal | decreases expression | ISO | MIOX (Homo sapiens) | 6480464 | propionaldehyde results in decreased expression of MIOX mRNA | CTD | PMID:26079696 | resveratrol | multiple interactions | ISO | MIOX (Homo sapiens) | 6480464 | [Plant Extracts co-treated with Resveratrol] results in decreased expression of MIOX mRNA | CTD | PMID:23557933 | sodium arsenite | increases expression | ISO | Miox (Mus musculus) | 6480464 | sodium arsenite results in increased expression of MIOX mRNA | CTD | PMID:37682722 | tebuconazole | decreases expression | ISO | MIOX (Homo sapiens) | 6480464 | tebuconazole results in decreased expression of MIOX mRNA | CTD | PMID:30458266 | Tesaglitazar | increases expression | EXP | | 6480464 | tesaglitazar results in increased expression of MIOX mRNA | CTD | PMID:21515302 | tetrachloroethene | decreases expression | ISO | Miox (Mus musculus) | 6480464 | Tetrachloroethylene results in decreased expression of MIOX mRNA | CTD | PMID:28973375 | titanium dioxide | increases expression | ISO | Miox (Mus musculus) | 6480464 | titanium dioxide results in increased expression of MIOX mRNA | CTD | PMID:23131501 | titanium dioxide | multiple interactions | ISO | Miox (Mus musculus) | 6480464 | [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of MIOX mRNA | CTD | PMID:29950665 | trichloroethene | increases expression | EXP | | 6480464 | Trichloroethylene results in increased expression of MIOX mRNA | CTD | PMID:33387578 | troglitazone | increases expression | EXP | | 6480464 | troglitazone results in increased expression of MIOX mRNA | CTD | PMID:21515302 | valproic acid | increases methylation | ISO | MIOX (Homo sapiens) | 6480464 | Valproic Acid results in increased methylation of MIOX gene | CTD | PMID:29154799 | vancomycin | increases expression | ISO | Miox (Mus musculus) | 6480464 | Vancomycin results in increased expression of MIOX mRNA | CTD | PMID:18930951 | zaragozic acid A | increases expression | ISO | Miox (Mus musculus) | 6480464 | squalestatin 1 results in increased expression of MIOX mRNA | CTD | PMID:27225895 | zaragozic acid A | increases expression | EXP | | 6480464 | squalestatin 1 results in increased expression of MIOX mRNA | CTD | PMID:27225895 | |